skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I presently hold ENF in an income portfolio. And before I make any change I would just like to verify my understanding of what I read yesterday. I take it that you would favour ALA over ENF for income. Here is the quote from yesterday's Q&A's comparing ENF to ALA:
"We would prefer ALA, for its dividend growth potential and expected growth from its acquisition strategy. We would not be too concerned on either dividend, but would consider ALA also a bit safer. It raised its dividend in October."
Read Answer Asked by David on November 30, 2017
Q: Hi Team, can I have your take on MRVL - Marvell Technology Group Ltd.
would this company be classified in the same industries as INTC, NVDA or TXN. Does it have a good growth prospect. I realize that you do not follow US stocks, but been hearing of this company for the first time in the last weeks and last couple days keeps coming up on US sites. Thank You in advance. Sam
Read Answer Asked by sam on November 30, 2017
Q: Do you still think xtc.to is an undervalued stock? Underwater by 40% so would this be a good stock for a tax loss? It has a horrific chart for the last two and half years.


EPS .18 for this quarter represents a p/e of 13.6 which is a premium to mg.to mre.to and lnr.to. Are you still
Confident in this company or move on to else. It has been a serious underperformer in the sector.

Last 1 year
MRE.TO + 100%
LNR.TO +33%
MG.TO +30%
XTC.TO -4.5%
Read Answer Asked by Thomas on November 30, 2017
Q: What would be your recommended ETF's for the following sectors that would provide safety and a regular monthly income . Financial, Consumer, Utilities ,, Energy, and Healthcare. I have noticed that you generally prefer for retired conservative investors like me to follow more the income portfolio.
Your comments and recommendations are appreciated. Thanks.
Read Answer Asked by Fred on November 30, 2017
Q: I know you have answered this question before (more than once). Could you please give me the link to the blog or article you wrote a while back that went through the type of investments that are most suitably held in an RRSP, a TFSA, a taxable cash account, etc. I could really use it when you wrote it. Now I have an opportunity to set up things more purposively and would like to review it. Thank you.
Read Answer Asked by Brian on November 30, 2017
Q: I am trying to decide which of these financial companies to invest in. Which has the best growth outlook for the next one to two years? Or would recommend another company.
Read Answer Asked by Paul on November 30, 2017
Q: Hello Peter and Ryan,
What do you think of Cannibix as a speculative play? Also, are you aware of companies that do breathalyzers for alcohol so that i can get an idea if the concept will take off from a market potential? Any idea why Aurora keeps going up while Cannimed is stagnant at 19-20 range when the offer is at 24? The results for Couche Tard were good. I would have expected a surge in the stock but it closed only a percentage higher. Was there anything in the news that may have tempered the stock price? Thanks very much.
Read Answer Asked by umedali on November 30, 2017
Q: I see on the Globe site there is a notice from a law company...

Johnson Fistel, Announces Investigations of INC Research Holdings, Inc., Acorda Therapeutics, Inc., and Shopify Inc.; Investors Encouraged to Contact Firm

Is this just another nuisance claim? The stock has dropped 7% today.

Just a note: I see Spin Master products being sold at Master Mind, Walmart and Canadian Tire. I don't think the Toys-R-Us problem will impact Spin Master sales in the long run.
Read Answer Asked by Bryan on November 30, 2017
Q: Hello Folks:
Could you please give me your view on Merck and Company (which along with Smith- Kline) has had problems executing new drugs (eg. lung cancer medications) in their pipelines. I also have previously owned Gilead, whose new HIV drug was reduced in value because of government pricing restrictions. My other health care equities are Johnson and Johnson and Knight Therapeutics. Do you think there are better health industry options (with decent dividends and growth potential) in the U.S. other than companies such as Merck, Gilead etc. or should one look to another sector.
Thanks for everything
brian
Read Answer Asked by Brian on November 30, 2017
Q: The tech meltdown hurt today, but the stocks which cost me the most weren't tech. Any idea why Visa and MasterCard were pummeled today? American Express was actually up on the day. And as long as we're on the subject, do you like the credit card companies?
Read Answer Asked by John on November 30, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!